期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

前列腺增生患者经尿道等离子体双极电切术后血清前列腺特异性抗原的变化 被引量：2

下载PDF
导出
摘要 目的:观察经尿道等离子体双极电切术(PKRP)对前列腺增生(BPH)患者血清中的总前列腺特异性抗原(t-PSA)和游离/总前列腺特异性抗原(f/tPSA)比值的影响,探讨其在PKRP术后随访中的意义。方法:对90例BPH患者行PKRP治疗,采用化学发光免疫法分别检测术前、术后24h及术后1、2、6个月患者血清中的t-PSA和f-PSA水平,并计算f/tPSA比值,随访比较分析手术前后PSA变化差异。结果:术后24h患者血清t-PSA值平均为(15.5±7.6)ng/mL,明显高于术前患者血清t-PSA值(6.2±5.5)ng/mL,差异有统计学意义(P<0.05)。术后1个月血清t-PSA值较术前明显降低,术后2个月降至最低,随后血清t-PSA趋于稳定;血清f/tPSA比值术前术后任何时段比较差异均无统计学意义(P>0.05)。结论:PKRP可显著降低BPH患者血清中的PSA,术后2个月PSA稳定至最低水平;与血清中的t-PSA和f-PSA水平相比,血清f/tPSA比值是PKRP术后短期及长期随访的一个更可靠指标。
作者 刘云飞 郑江 刘昌茂 夏安 代海涛
机构地区 长江大学附属第一医院泌尿外科
出处 《实用医学杂志》 CAS 北大核心 2010年第5期775-776,共2页 The Journal of Practical Medicine
关键词 前列腺增生 前列腺特异性抗原 等离子体双极电切
分类号 R699 [医药卫生—泌尿科学]
  • 相关文献

参考文献6

  • 1Levitt J M, Slawin K M. Prostate-specific antigen and prostatespecific antigen derivatives as predictors of benign prostatic hyperplasia progression [J]. Curr Urol Rep, 2007, 8(4): 269-274.
  • 2van Renterghem K, Van Koeveringe G, Achten R, et al. Clinical relevance of transurethral resection of the prostate in "asymptomatie" patients with an elevated prostate-specific antigen level [J]. Eur Urol, 2007, 52(3): 819-826.
  • 3王行环,王怀鹏,陈浩阳,刘久敏,罗耀雄,冯自卫,罗则民.经尿道等离子体双极电切术治疗良性前列腺增生及膀胱肿瘤[J].中华泌尿外科杂志,2003,24(5):318-320. 被引量：267
  • 4曾科,李洪勤,王可超,李政,潘校诚,肖泽钊.经尿道等离子双极电切术治疗良性前列腺增生85例[J].实用医学杂志,2007,23(2):247-248. 被引量：1
  • 5Volkan T, Ihsan T A, Yilmaz O, et al. Short term outcomes of high power (80W) potassium-titanyl-phosphate laser vaporization of the prostate [J]. Eur Urol, 2005, 48(4):608-613.
  • 6Gupta N, Sivaramakrish N A, Kumar R, et al. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40g [J]. BJU Int, 2006, 97( 1 ):85-89.

二级参考文献11

  • 1郭晓日.经尿道双极动态等离子体汽化治疗前列腺增生[J].实用医学杂志,2005,21(18):2063-2064. 被引量：4
  • 2Botto H,Lebret T, Barre P, et al. Electrovaporization of prostate with the Gyrus Device. J Endourol,2001,15 : 319-322.
  • 3Ramsey EW. Benign prostatic hyperplasia: a review. Can J Urol,2000,7 : 1135-1143.
  • 4Mebust W, Hohgrewe H, Coeket APC, et al. Transurethral prostectomy: immediate and post operative complication. A comparative study of 13 participating institution evaluating 3 885 patients. J Uro1,1989,141:243-247.
  • 5Virdi J, Kapasi F, Chandrasekar P, et al. A prospective randomized study between transurethral vaporization using plasmakinetic energy and transurethral resection of the prostate. J Urol,2000,163 (4 suppl) :268-269.
  • 6Donovan JL, Peters TJ, Neal DE, et al. A randomized trial comparing transurethral resection of the prostate,laser therapy and conservative treatment of men with symptoms associated with benign pro6tatic enlargement : the CLasP study. J Urol,2000 ,164 :65-70.
  • 7Reich O,Schneede P,Zaak D,et al,Ex-vivo comparison of the haemostatic properties of standard transurethral resection and tranansurethral Vaporization resection of prostate[J].BJU Int,2003,92 (3):319-322.
  • 8Mebust W K,Holtgrewe H L,Cockett A T,et al.Transurethral prostatectomy:immediate and postoperative complications.Cooperative study of 13 participating institions evaluating 3,885patients[J].J Urol,2002,167 (1):5-9.
  • 9余良,刘春晓,张凤林,郑少波,李虎林,徐亚文.经尿道双极气化治疗前列腺增生的疗效观察(附50例报告)[J].临床泌尿外科杂志,2001,16(10):450-452. 被引量：274
  • 10卢小刚.经尿道电切术与经尿道汽化切割术治疗良性前列腺增生症[J].实用医学杂志,2002,18(6):569-570. 被引量：4

共引文献266

同被引文献18

  • 1陈冰,马青松,梁凤泉,孙希刚,任保入,解建军,任玉波.细针穿刺细胞块及血清前列腺特异性抗原浓度测定对前列腺癌的诊断价值[J].中国全科医学,2008,11(19):1757-1760. 被引量：6
  • 2TANGUARY S,BEJIN L R,ELHILALI M M,et al.Comparative evaluation of total PSA,free/total PSA,and complexed PSA in prostate cancer detection[J].Urology,2002,59(2):261-265.
  • 3Yoshitomo Kobori,Yasuhide Kitagawa,Atsushi Mizokami,Kazuto Komatsu,Mikio Namiki.Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1–10.0 ng/ml as a criterion[J].International Journal of Clinical Oncology.2008(3)
  • 4M. Sheikh,O. Al-Saeed,E.O. Kehinde,T. Sinan,J. T. Anim,Y. Ali.Utility of Volume Adjusted Prostate Specific Antigen Density in the Diagnosis of Prostate Cancer in Arab Men[J].International Urology and Nephrology.2005(4)
  • 5Partin A W,Kattan M W,Subong E N,et al.Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update[].The Journal of the American Medical Association.1997
  • 6Gupta N,Sivaramakrishna,Kumar R,et al.Comparison of standard transurethral resection,transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyper-plasia of&gt;40g[].BJUInt.2006
  • 7Ishidoya S,Ito A,Orikasa K,et al.The outcome of pros-tate cancer screening in a normal Japanese population withPSA of 2-4ng/ml and the free/total PSA under 12%[].Japanese Journal of Clinical Oncology.2008
  • 8Zlotta AR,Djavan B,Marberger M,et al.Prostate specific antigen density of the transitional zone: a new effective parameter for prostate cancer prediction[].Journal d Urologie.1997
  • 9ZLgeuner R E,psky K,Riedler I,et al.Did the rate of inciden-talprostate cancer change in the era of PSA testing,a retrospectivestudy of 1127 patients[].Urology.2003
  • 10Volkan T,Ihsan TA,Yilmaz O,et al.Short term outcomes of high power (80W)potassium litany phosphate laser va-porization of the prostate[].European Urology.2005

引证文献2

二级引证文献4

实用医学杂志
2010年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部